TITLE

Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway

AUTHOR(S)
Guo, Bo; Wang, Wenjing; Zhao, Zhenghao; Li, Qian; Zhou, Kaiyue; Zhao, Lingyu; Wang, Lumin; Yang, Juan; Huang, Chen
PUB. DATE
January 2017
SOURCE
PLoS ONE;1/20/2017, Vol. 12 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Rab14 is a member of RAS oncogene family, and its dysfunction has been reported to be involved in various types of human cancer. However, its expression and function were still unclear in gastric cancer. The aim of this study was to investigate the function and mechanism of Rab14 in gastric cancer cell lines. Quantitative real-time PCR (qRT-PCR) was performed in 17 gastric adenocarcinoma tissues and 4 cell lines to detect the expression of Rab14. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT), colony formation and flow cytometry assays were employed to determine the proliferative ability, cell cycle transition and apoptosis in vitro in BGC-823 or SGC-7901 cells. Western blot was performed to investigate the pathways and mechanism of Rab14 regulation. In this study, we show that Rab14 presents a significant up-regulated expression among the paired tissue samples and cell lines in gastric cancer. When we overexpressed Rab14 in SGC-7901 cells or silenced Rab14 in BGC-823 cells, we found that Rab14 could modify cell growth, cell cycle or apoptosis, which accompanied with an obvious regulation of CCND1, CDK2 and BAX involving in AKT signaling pathway. In conclusion, this study provides a new evidence on that Rab14 functions as a novel tumor oncogene and could be a potential therapeutic target in gastric cancer.
ACCESSION #
120873860

 

Related Articles

  • Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway. Chao, Yuewen; Wang, Yan; Liu, Xuejiao; Ma, Peng; Shi, Yi; Gao, Jian; Shi, Qiong; Hu, Jinxia; Yu, Rutong; Zhou, Xiuping // Journal of Neuro-Oncology;Jan2015, Vol. 121 Issue 2, p279 

    Mammalian sterile 20-like 1 (Mst1), an upstream serine/threonine-specific protein kinase of the Hippo pathway, is reported to play important roles in tumor suppression and organ size regulation in mammals via regulating cell proliferation and survival. However, whether it is involved in the...

  • Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA. Gulhati, Pat; Zaytseva, Yekaterina Y; Valentino, Joseph D; Stevens, Payton D; Kim, Ji Tae; Sasazuki, Takehiko; Shirasawa, Senji; Lee, Eun Y; Weiss, Heidi L; Dong, Jianli; Gao, Tianyan; Evers, B. Mark // Carcinogenesis;Sep2012, Vol. 33 Issue 9, p1782 

    Activation of phosphatidylinositol 3-kinase (PI3K)/Akt signaling is associated with tumorigenesis and metastasis of colorectal cancer (CRC). The mammalian target of rapamycin (mTOR) kinase, a downstream effector of PI3K/Akt signaling, regulates tumorigenesis and metastasis of CRCs, indicating...

  • The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis. Zhou, C; Licciulli, S; Avila, J L; Cho, M; Troutman, S; Jiang, P; Kossenkov, A V; Showe, L C; Liu, Q; Vachani, A; Albelda, S M; Kissil, J L // Oncogene;2/14/2013, Vol. 32 Issue 7, p903 

    Rac1b, an alternative splice form of Rac1, has been previously shown to be upregulated in colon and breast cancer cells, suggesting an oncogenic role for Rac1b in these cancers. Our analysis of NSCLC tumor and matched normal tissue samples indicates Rac1b is upregulated in a significant fraction...

  • Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Alikhani, N; Ferguson, R D; Novosyadlyy, R; Gallagher, E J; Scheinman, E J; Yakar, S; LeRoith, D // Oncogene;2/21/2013, Vol. 32 Issue 8, p961 

    Dyslipidemia has been associated with an increased risk for developing cancer. However, the implicated mechanisms are largely unknown. To explore the role of dyslipidemia in breast cancer growth and metastasis, we used the apolipoprotein E (ApoE) knockout mice (ApoE−/−), which...

  • 69P SAFETY AND EFFICACY OF MK-8669 (RIDAFOROLIMUS) + MK-2206 (AKT INHIBITOR) IN PATIENTS WITH ADVANCED BREAST CANCER WITH PI3K PATHWAY DEPENDENCE. Gupta, S.; Munster, P.; Hollebecque, A.; Argiles, G.; Guren, T.; Cheng, J.; Wang, R.; Swift, A.; Tosolini, A.; Piha-Paul, S. // Annals of Oncology;May2014 Supplement 1, Vol. 25 Issue suppl_1, pi25 

    No abstract available.

  • Pro-apoptotic and anti-proliferative effects of mitofusin-2 via PI3K/Akt signaling in breast cancer cells. LI MA; YUAN CHANG; LONG YU; WENBO HE; YUEPING LIU // Oncology Letters;Dec2015, Vol. 10 Issue 6, p3816 

    The mitochondrial GTPase mitofusin-2 (Mfn2) gene is a novel gene characterized as a cell proliferation inhibitor. Mfn2 has previously been reported to play a role in regulating cell proliferation, apoptosis and differentiation in a number of cell types. However, there are no studies on the...

  • PDK1 controls upstream PI3K expression and PIP3 generation. Dieterle, A M; Böhler, P; Keppeler, H; Alers, S; Berleth, N; Drießen, S; Hieke, N; Pietkiewicz, S; Löffler, A S; Peter, C; Gray, A; Leslie, N R; Shinohara, H; Kurosaki, T; Engelke, M; Wienands, J; Bonin, M; Wesselborg, S; Stork, B // Oncogene;6/5/2014, Vol. 33 Issue 23, p3043 

    The PI3K/PDK1/Akt signaling axis is centrally involved in cellular homeostasis and controls cell growth and proliferation. Due to its key function as regulator of cell survival and metabolism, the dysregulation of this pathway is manifested in several human pathologies including cancers and...

  • SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness. Tian, Yajun; Jia, Xin; Wang, Shengxiang; Li, Yongsheng; Zhao, Peng; Cai, Da; Zhou, Zequan; Wang, Junmin; Luo, Yi; Dong, Maosheng // Journal of Cancer Research & Clinical Oncology;Jul2014, Vol. 140 Issue 7, p1117 

    Introduction: Gastric cancer is the second leading cause of cancer mortality in the world. Whether the oncogene, amplified on chromosome 3q26, SOX2, a master transcriptional regulator of stemness, operate to drive strong growth phenotype in gastric cancer were unknown. Materials and methods: The...

  • CD44 promotes Kras-dependent lung adenocarcinoma. Zhao, P; Damerow, M S; Stern, P; Liu, A H; Sweet-Cordero, A; Siziopikou, K; Neilson, J R; Sharp, P A; Cheng, C // Oncogene;10/24/2013, Vol. 32 Issue 43, p5186 

    Kras-induced non-small-cell lung adenocarcinoma is the major subtype of lung cancers and is associated with poor prognosis. Using a lung cancer mouse model that expresses a cre-mediated KrasG12D mutant, we identified a critical role for the cell surface molecule CD44 in mediating cell...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics